News In Brief from “The Gold Sheet” on LinkedIn
This article was originally published in The Gold Sheet
Ben Venue shuttered; Teva squeezed; Wockhardt troubled; McKinsey would cut inventories and shortages; FDA says why it won’t review some ANDAs – what are they saying about it at “The Gold Sheet” on LinkedIn? Join the discussions of these and other recent news developments at “The Gold Sheet” LinkedIn group.
You may also be interested in...
Why EU GMP certificate suspensions hit two Chinese API firms and an Austrian drug maker, and why Wockhart site’s suspension was expanded to include critical APIs.